Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Gesine RespondekCarolin KurzThomas ArzbergerYaroslau ComptaElisabet EnglundLeslie W FergusonEllen GelpiArmin GieseDavid J IrwinWassillios G MeissnerChrister NilssonAlexander PantelyatAlex RajputJohn C van SwietenClaire TroakesKeith A JosephsAnthony E LangBrit MollenhauerUlrich MüllerJennifer L WhitwellAngelo AntoniniKailash P BhatiaYvette BordelonJean-Christophe CorvolCarlo ColosimoRichard DodelMurray GrossmanJan KassubekFlorian KrismerJohannes LevinStefan LorenzlHuw MorrisPeter NestorWolfgang H OertelGil D RabinoviciJames B RoweThilo van EimerenGregor K WenningAdam BoxerLawrence I GolbeIrene LitvanMaria StamelouGünter U Höglingernull nullPublished in: Movement disorders : official journal of the Movement Disorder Society (2017)
Our results highlight the clinical variability of PSP and the high prevalence of phenotypes other than Richardson's syndrome. The features of variant phenotypes with high specificity and sensitivity should serve to optimize clinical diagnosis of PSP. © 2017 International Parkinson and Movement Disorder Society.
Keyphrases